Limits in reliability of glycoprotein G-based type-specific serologic assays for herpes simplex virus types 1 and 2

Journal of Clinical Microbiology

Volumn 37, Issue 2, 1999, Pages 376-379

  Schmid, D Scott ^a,e   Brown, Denise R ^a   Nisenbaum, Rosane ^b   Burke, Rae Lyn ^c   Alexander, D'Anna ^c   Ashley, Rhoda ^d   Pellett, Philip E ^a   Reeves, William C ^a  

^a CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

^b Klemm Analysis Group   (United States)

^c NOVARTIS PHARMA AG   (Switzerland)

^d UNIVERSITY OF WASHINGTON   (United States)

^e NATL CENTER FOR INFECTIOUS DISEASES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

THROMBOSPONDIN;

ADULT; ARTICLE; ENZYME LINKED IMMUNOSORBENT ASSAY; HERPES SIMPLEX VIRUS 1; HERPES SIMPLEX VIRUS 2; HERPES VIRUS INFECTION; HUMAN; IMMUNOASSAY; IMMUNOBLOTTING; MAJOR CLINICAL STUDY; NONHUMAN; PRIORITY JOURNAL; SEROCONVERSION; VIRUS DETECTION; WESTERN BLOTTING;

EID: 0032959965     PISSN: 00951137     EISSN: None     Source Type: Journal    
DOI: 10.1128/jcm.37.2.376-379.1999     Document Type: Article

References (30)

1. Alexander, D., J. Kilpatrick, R. Ashley, L. Corey, R. Dinello, A. Polito, and R. L. Burke. 1994. Recombinant-truncated gG1 and gG2 as antigens for a type-specific serological assay to diagnose prior infection with HSV-1 or HSV-2, abstr. 283. International Herpesvirus Workshop, Vancouver, Canada.
2. Ashley, R. 1995. Herpes simplex virus, p. 375-395. In E Lennette (ed.), Diagnostic procedures for viral, rickettsial and chlamydial infections, 7th ed. American Public Health Association, Washington, D.C.
3. Benedetti, J. L. Corey, and R. Ashley. 1994. Recurrence rates in genital herpes after symptomatic first-episode infection. Ann. Intern. Med. 121:847-854.
4. Bernstein, D. I., M. A. Lovett, and Y. J. Bryson. 1984. Serologic analysis of first-episode nonprimary genital herpes simplex virus infection. Am. J. Med. 77:1055-1060.
5. Brown, Z. A., J. K. Benedetti, D. H. Watts, S. Selke, S. Berry, R. L. Ashley, and L. Corey. 1995. A comparison between detailed and simple histories in the diagnosis of genital herpes complicating pregnancy. Am. J. Obstet. Gynecol. 172:1299-1303.
6. Davidson, M., P. G. Schnitzer, L. R. Bulkow, A. J. Parkinson, M. L. Schloss, M. A. Fitzgerald, J. A. Knight, C. M. Murphy, N. B. Kiviat, K. E. Toomey, W. C. Reeves, D. S. Schmid, and W. E. Stamm. 1994. The prevalence of cervical infection with human papillomaviruses and cervical dysplasia in Alaska native women. J. Infect. Dis. 169:792-800.
7. Dolan, A., F. E. Jamieson, C. Cunningham, B. C. Barnett, and D. J. McGeoch. 1998. The genome sequence of herpes simplex virus type 2. J. Virol. 72:2010-2021.
8. Faruque, S., B. R. Edlin, C. B. McCoy, C. O. Word, S. A. Larsen, D. S. Schmid, J. C. von Bargen, and Y. Serrano. 1996. Crack cocaine smoking and oral sores in three inner-city neighborhoods. J. Acquired Immune Defic. Syndr. Hum. Retroviruses 13:87-92.
9. Ho, D. W. T., P. R. Field, E. Sjögren-Jansson, S. Jeansson, and A. L. Cunningham. 1992. Indirect ELISA for the detection of HSV-2 specific IgG and IgM antibodies with glycoprotein G (gG-2). J. Virol. Methods 36:249-264.
10. Johnson, R. E., A. J. Nahmias, L. S. Magder, F. K. Lee, C. A. Brooke, and C. B. Snowden. 1989. A seroepidemiologic survey of the prevalence of herpes simplex virus type 2 infection in the United States. N. Engl. J. Med. 321:7-12.
11. Kahlon, J., F. D. Lakeman, M. Ackermann, and R. J. Whitley. 1986. Human antibody response to herpes simplex virus-specific polypeptides after primary and recurrent infection. J. Clin. Microbiol. 23:725-730.
12. Koutsky, L. A., R. L. Ashley, K., K. Holmes, C. E. Stevens, C. W. Critchlow, N. Kiviat, C. M. Lipinski, P. Wolner-Hanssen, and L. Corey. 1990. The frequency of unrecognized type 2 herpes simplex virus infection among women. Implications for the control of genital herpes. Sex. Transm. Dis. 17:90-94.
13. Kulhanjian, J. A., V. Soroush, D. S. Au, R. N. Bronzan, L. L. Yasukawa, L. E. Weylman, A. M. Arvin, and C. G. Prober. 1992. Identification of women at unsuspected risk of primary infection with herpes simplex virus type 2 during pregnancy. N. Engl. J. Med. 326:916-920.
14. Landis, J. R., and G. E. Koch. 1977. The measurement of observer agreement for categorical data. Biometrics 33:159-174.
15. Langenberg, A., J. Benedetti, J. Jenkins, R. Ashley, C. Winter, and L. Corey. 1989. Development of clinically recognizable genital lesions among women previously identified as having "asymptomatic" herpes simplex virus type 2 infection. Ann. Intern. Med. 110:882-887.
16. Lasky, L. A., and D. J. Dowbenko. 1984. DNA sequence analysis of the type-common glycoprotein D genes of herpes simplex types 1 and 2. DNA 3:23-29.
17. Lee, F. K., R. M. Coleman, L. Pereira, P. D. Bailey, M. Tatsuno, and A. J. Nahmias. 1985. Detection of herpes simplex virus type-2 specific antibody with glycoprotein G. J. Clin. Microbiol. 22:641-644.
18. Lee, F. K., L. Pereira, C. Griffen, E. Reid, and A. J. Nahmias. 1986. A novel glycoprotein (gG-1) for detection of herpes simplex virus specific antibodies. J. Virol. Methods 14:111-118.
19. Marsden, H. S., A. Buckmaster, J. W. Palfreyman, R. G. Hope, and A. C. Minson. 1984. Characterization of the 92,000-dalton glycoprotein induced by herpes simplex virus type 2. J. Virol. 50:547-554.
20. McGeoch, D. J., H. W. Moss, D. McNab, and M. C. Frame. 1987. DNA sequence and genetic content of the HindIII region in the short unique component of herpes simplex virus type 2 genome: identification of the gene encoding glycoprotein G, and evolutionary comparisons. J. Gen. Virol. 68: 19-38.
21. Rapoport, T. A. 1986. Protein translocation across and integration into membranes. Crit. Rev. Biochem. 20:73-137.
22. Reeves, W. C., H. E. Gary, Jr., P. R. Johnson, J. P. Icenogle, M. M. Brenes, R. M. deBritton, J. G. Dobbins, and D. S. Schmid. 1994. Risk factors for genital papillomavirus infection in populations at high and low risk for cervical cancer. J. Infect. Dis. 170:753-758.
23. Roizman, B., B. Norrild, C. Chan, and L. Pereira. 1984. Identification and preliminary mapping with monoclonal antibodies of a herpes simplex virus 2 glycoprotein lacking a known type 1 counterpart. Virology 133:242-247.
24. Safrin, S., A. Arvin, J. Mills, and R, Ashley. 1992. Comparison of the Western immunoblot assay and a glycoprotein G enzyme immunoassay for detection of serum antibodies to herpes simplex virus type 2 in patients with AIDS. J. Clin. Microbiol. 30:1312-1314.
25. Sánchez-Martínez, D., and P. E. Pellett. 1991. Expression of HSV-1 and HSV-2 glycoprotein G in insect cells using a novel baculovirus expression vector. Virology 182:229-238.
26. Sánchez-Martínez, D., D. S. Schmid, W. Whittington, D. Brown, W. C. Reeves, S. Chatterjee, R. J. Whitley, and P. E. Pellett. 1991. Evaluation of a test based on baculovirus-expressed glycoprotein G for detection of herpes simplex virus type-specific antibodies. J. Infect. Dis. 164:1196-1199.
27. Spear, P. G. 1985. Glycoproteins specified by herpes simplex viruses, p. 315-356. In B. Ruizman (ed.). The herpesviruses. vol. 3. Plenum Press, New York, N.Y.
28. Sweat, M. D., T. Nopkesorn, T. D. Mastro, S. Sangkharomya, K. MacQueen, W. Pokapanichwong, Y. Sawaengdee, and B. G. Weniger. 1995. AIDS awareness among a cohort of young Thai men: exposure to information, level of knowledge, and perception of risk. AIDS Care 7:573-591.
29. Tedder, D. G., R. Ashley, K. L. Tyler, and M. J. Levin. 1994. Herpes simplex virus infection as a cause of benign recurrent lymphocytic meningitis. Ann. Intern. Med. 121:334-338.
30. Wagner, H. U., E. Van Dyck, E. Roggen, A. J. Nunn, A. Kamali, D. S. Schmid, J. G. Dobbins, and D. W. Mulder. 1994. Seroprevalence and incidence of sexually transmitted diseases in a rural Ugandan population. Int. J. Sex. Transm. Dis. AIDS 5:332-337.